REGISTERED
on 23 May 2023
Last Applicant/ Owned by
Thurgauerstrasse 130
Glattpark-Opfikon
CH
8152
Serial Number
97333970 filed on 28th Mar 2022
Registration Number
7059516 registered on 23rd May 2023
Correspondent Address
Karl M. Zielaznicki, Esq.
Filing Basis
1. intent to use
Disclaimer
NO DATA
SOZEMPA
Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
Mark Details
Serial Number
No 97333970
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 256532000268
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd May 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd May 2023 | REGISTERED-PRINCIPAL REGISTER |
| 07th Mar 2023 | PUBLISHED FOR OPPOSITION |
| 07th Mar 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Feb 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 31st Jan 2023 | EXAMINER'S AMENDMENT ENTERED |
| 31st Jan 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 31st Jan 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 31st Jan 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Jan 2023 | EXAMINERS AMENDMENT E-MAILED |